枯草杆菌二联活菌肠溶胶囊联合多烯磷脂酰胆碱治疗NAFLD疗效及对血清Pygo2、HMGB1和HIF-1α的影响

doi:10.3969/j.issn.1672-5069.2018.04.022

摘要/Abstract

摘要： 目的探讨枯草杆菌二联活菌联合多烯磷脂酰胆碱治疗非酒精性脂肪性肝病（NAFLD）患者的疗效及其对血清人尾肢同源蛋白2（Pygo2）、高迁移率族蛋白B1（HMGB1）和人缺氧诱导因子1α（HIF-1α）的影响。方法 2015年6月~2016年6月我院诊治的78例NAFLD患者被随机分为观察组39例和对照组39例,分别给予多烯磷脂酰胆碱和枯草杆菌二联活菌或单纯多烯磷脂酰胆碱治疗,观察3 m。采用ELISA法检测血清Pygo2、HMGB1和HIF-1α水平。结果在治疗3 m末,观察组血清TG、TC、LDL-C和HDL-C水平分别为（1.2±0.2） mmol/L、（4.1±0.2） mmol/L、（3.1±0.1） mmol/L和（3.9±0.3） mmol/L,与对照组的（1.6±0.3） mmol/L、（5.1±0.3） mmol/L、（3.5±0.2） mmol/L和（3.2±0.2） mmol/L比,存在显著性差异（P<0.05）;血清MDA和SOD水平分别为（4.4±0.7） μmol/L和（168.9±15.7） U/L,与对照组的（5.4±0.8）μmol/L和（154.4±15.3） U/L比,存在显著性差异（P<0.05）;血清Pygo2、HMGB1和HIF-1α水平分别为（41.5±3.4） μg/L、（15.7±4.6） μg/L和（24.5±4.6） μg/L,明显低于对照组[（48.2±3.7） μg/L、（26.4±5.1） μg/L和（32.6±4.7） μg/L,P<0.05];脂肪肝分度为正常、轻度、中度和重度的比例分别为56.4%、35.9%、5.1%和2.6%,显著优于对照组(分别为10.3%、30.8%、41.0%和17.9%,P<0.05)。结论枯草杆菌二联活菌联合多烯磷脂酰胆碱治疗NAFLD患者效果显著,可有效改善血脂水平,减轻氧化应激状态,具有良好的临床应用价值。

关键词: 非酒精性脂肪性肝病, 枯草杆菌二联活菌, 多烯磷脂酰胆碱, 治疗

Abstract: Objective To investigate the efficacy of bacillus subtilis duplex and polyene phosphatidylcholine combination in the treatment of patients with nonalcoholic fatty liver diseases （NAFLD） and its effects on serum people end limb homologous protein 2（Pygo2）,high mobility group protein B1（HMGB1） and hypoxia inducible factor-1α （HIF-1α） levels. Methods 78 patients with NAFLD admitted to our hospital between June 2015 and June 2016 were divided randomly into observation（n=39） and control group （n=39）,and received bacillus subtilis duplex and polyene phosphatidylcholine combination or the latter alone for three months. Serum Pygo2,HMGB1 and HIF-1α were detected by using ELISA. Results At the end of three month treatment,serum levels of TG, TC,LDL-C and HDL-C in the observation group were（1.2±0.2） mmol/L,（4.1±0.2） mmol/L,（3.1±0.1） mmol/L and （3.9±0.3） mmol/L,significantly different compared to[（1.6±0.3） mmol/L,（5.1±0.3） mmol/L,（3.5±0.2） mmol/L and （3.2±0.2） mmol/L in the control,P<0.05];serum levels of MDA and SOD were （4.4±0.7） μmol/L and （168.9±15.7） U/L,significantly different compared to[（5.4±0.8） μmol/L and（154.4±15.3） U/L in the control,P<0.05]; serum levels of Pygo2,HMGB1 and HIF-1 alpha were（41.5±3.4）μg/L,（15.7±4.6） μg/L and（24.5±4.6）μg/L, respectively, significantly lower than [（48.2±3.7） μg/L,（26.4±5.1） μg/L and（32.6±4.7） μg/L in the control,P<0.05]; the percentages of normal liver, and mild, moderate and severe fatty liver were 56.4%,and 35.9%,5.1% and 2.6%,respectively,significantly better than（10.3%, and 30.8%,41.0% and 17.9%,P<0.05） in the control. Conclusion The application of bacillus subtilis duplex and polyene phosphatidylcholine combination in the treatment of patients with NAFLD is clinically efficient,which might effectively improve blood lipid imbalance,inhibit oxidative stress,and reduce serum Pygo2,HMGB1 and HIF-1α levels.

Key words: Non-alcoholic fatty liver diseases, Bacillus subtilis, Polyene Phosphatidylcholine, Therapy

刘扬河, 龙登毅, 贝筝, 凌萌智, 张艳, 蔡笃雄. 枯草杆菌二联活菌肠溶胶囊联合多烯磷脂酰胆碱治疗NAFLD疗效及对血清Pygo2、HMGB1和HIF-1α的影响[J]. 实用肝脏病杂志, 2018, 21(4): 573-576.

Liu Yanghe, Long Dengyi, Bei Zheng, et al. Efficacy of bacillus subtilis duplex and polyene phosphatidylcholine combination in treatments of patients with nonalcoholic fatty liver diseases[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 573-576.

参考文献

[1] SHanab AA,Scully P,Crosbie O,et al.Small intestinal bacterial overgrowth in non-alcoholic steatohepatitis:association with Toll-like receptor 4 expression and plasma levels of interleukin 8. Dig Dis Sci,2011,56(5) :1524-1534.
[2] Targher G,Day CP,Bonor a E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med,2010,363(14):1341-1350.
[3] 李笠,梁学亚. 水飞蓟宾葡甲胺联合多烯磷脂酰胆碱治疗酒精性脂肪肝患者初步临床研究. 实用肝脏病杂志,2017,20(4):412-415.
[4] Hung B,Ban X,He J,et al.Comparative analysis of essential oil components and antioxidant activity of extracts of Nelumbo nucifera from various areas of China. Agric Food Chem,2010,58(1):441-448.
[5] Lin Z,Tian H,Lam KS,et al.Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice. Cell Metab,2013,17(5):779-789.
[6] 中华医学会肝脏病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南. 实用肝脏病杂志,2007,10(1):1-3.
[7] Drab SR.Clinical studies of liraglutide,a novel,oncedaily human glucagons-like peptide-1 analog for improved management of type 2 diabetes mellitus. Pharmacotherapy,2009,29(12Pt2):43S-54S.
[8] 刘晓琳,范建高. 2017年亚太地区肝病年会非酒精性脂肪性肝病研究报道. 实用肝脏病杂志,2017,20(3):387-390.
[9] Kharitonenkov A,Wroblewski VJ,Koester A,et al.The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21.Endocrinology,2007,148(2):774-781.
[10] Ogawa Y,Kurosu H,Yamamoto M,et al.Beta Klotho is required for metabolic activity of fibroblast growthfactor-2l. Proc Natl Acad Sci USA,2007,104(18):7432-7437.
[11] Shih MH,Lazo M,Liu SH,et al.Association between serum uric acid and nonalcoholic fatty liver disease in the US population. J Formos Med Assoc,2015,114(4):314-320.
[12] 杨林辉,郭昭友,曹明,等. 枯草杆菌肠球菌二联活菌胶囊对非酒精性脂肪性肝炎患者血清内毒素水平的影响. 实用肝脏病杂志,2012,15(2):101-103.
[13] Li W,Zhu C,Wu Y,et al.Increased Pygo2 expression in liver of patients with hepatitis B virus related fibrosis. Liver Int,2015,35(12):2522-2529.
[14] Xu C,Wan X,Xu L,et al.Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: one stone hits two birds. J Hepatol,2015,62(6):1412-1419.
[15] Gwak GY,Moon TG,Lee DH,et al.Glycyrrhizin attenuates HMGB1-induced hepatocyte apoptosis by inhibiting the p38-dependent mitochondrial pathway. World J Gastroenterol,2012,18(7):679-684.
[16] Sun DQ,Wu SJ,Liu WY,et al.Serum uric acid:a new therapeutic target for nonalcoholic fatty liver disease. Expert Opin Ther Targets,2016,20(3):3759387.
[17] 管红雨,蔡晓波,陆伦根. 缺氧对非酒精性脂肪性肝病发病的影响. 实用肝脏病杂志,2016,19(2):237-240.
[18] Yuan H,Yu C,Li X,et al.Serum uric acid levels and risk of metabolic syndrome:a dose-response Meta-analysis of prospective studies. J Clin Endocrinol Metab,2015,200(11):4198-4207.
[19] Sirota JC,Mcfann K,Targher G,et al.Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States:liver ultrasound data from the National Health and Nutrition Examination Survey. Metabolism,201362(3):392-399.
[20] 陈海姣,刘鹏飞,张伟,等. HIF-1α、NF-κB在大鼠不同程度非酒精性脂肪肝中的表达. 世界华人消化杂志,2014,22(35):5480-5485.